Literature DB >> 30191991

Potential therapeutic effects of curcumin in gastric cancer.

Nastaran Barati1, Amir A Momtazi-Borojeni2,3, Muhammed Majeed4, Amirhossein Sahebkar5,6,7.   

Abstract

Despite recent advancements in understanding of the biology of gastric cancer, treatment of patients with advanced gastric cancer remains a major problem. Among different type of phytochemicals, curcumin, a welltable -known phytochemical, has been shown to be a promising cancer chemopreventive agent. Pharmacokinetics, safety, and efficacy of curcumin have been evaluated in several clinical trials against numerous diseases, and for the treatment of human cancer. In the present review, we have collected in vitro and in vivo investigations and studied the chemosensitizing and anticancer effects of curcumin against the gastric cancer cells. In summary, curcumin has been found to have efficient chemosensitizing effect and also inhibits viability, proliferation, and migration of gastric cancer cells mainly via cell cycle arrest and induction of apoptosis by both mitochondrial-dependent and -independent pathways.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  apoptosis; chemosensitization; curcumin; gastric cancer; phytochemical

Mesh:

Substances:

Year:  2018        PMID: 30191991     DOI: 10.1002/jcp.27229

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  20 in total

1.  Investigation of the Effects of Difluorinated Curcumin on Glycemic Indices in Streptozotocin-Induced Diabetic Rats.

Authors:  Shabnam Radbakhsh; Amir Abbas Momtazi-Borojeni; Ali Mahmoudi; Mohammad Reza Sarborji; Mahdi Hatamipour; Seyed Adel Moallem; Stephen L Atkin; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Potential therapeutic effects of Ivermectin in COVID-19.

Authors:  Nastaran Barati; Seyedmousa Motavallihaghi; Banafsheh Nikfar; Shahla Chaichian; Amir Abbas Momtazi-Borojeni
Journal:  Exp Biol Med (Maywood)       Date:  2022-06-10

3.  99mTc Radiolabeled HA/TPGS-Based Curcumin-Loaded Nanoparticle for Breast Cancer Synergistic Theranostics: Design, in vitro and in vivo Evaluation.

Authors:  Chong Huang; Fen Chen; Ling Zhang; Yue Yang; Xinggang Yang; Weisan Pan
Journal:  Int J Nanomedicine       Date:  2020-04-30

4.  Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer.

Authors:  Chao Hong; Dan Wang; Jianming Liang; Yizhen Guo; Ying Zhu; Jiaxuan Xia; Jing Qin; Huaxing Zhan; Jianxin Wang
Journal:  Theranostics       Date:  2019-06-09       Impact factor: 11.556

Review 5.  Potential Mechanisms of Action of Curcumin for Cancer Prevention: Focus on Cellular Signaling Pathways and miRNAs.

Authors:  Man Wang; Shuai Jiang; Li Zhou; Fei Yu; Han Ding; Peifeng Li; Meng Zhou; Kun Wang
Journal:  Int J Biol Sci       Date:  2019-05-07       Impact factor: 6.580

6.  Development of dual-targeted nano-dandelion based on an oligomeric hyaluronic acid polymer targeting tumor-associated macrophages for combination therapy of non-small cell lung cancer.

Authors:  Bingjie Wang; Wei Zhang; Xiudi Zhou; Mengna Liu; Xiaoya Hou; Ziting Cheng; Daquan Chen
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

Review 7.  Nanoparticles Targeting STATs in Cancer Therapy.

Authors:  Milad Ashrafizadeh; Zahra Ahmadi; Niranjan G Kotla; Elham Ghasemipour Afshar; Saeed Samarghandian; Ali Mandegary; Abbas Pardakhty; Reza Mohammadinejad; Gautam Sethi
Journal:  Cells       Date:  2019-09-27       Impact factor: 6.600

8.  Curcumin, demethoxycurcumin, and bisdemethoxycurcumin induced caspase-dependent and -independent apoptosis via Smad or Akt signaling pathways in HOS cells.

Authors:  Cheng Huang; Hsu-Feng Lu; Yu-Hsuan Chen; Jui-Chieh Chen; Wen-Hsiang Chou; Hsiu-Chen Huang
Journal:  BMC Complement Med Ther       Date:  2020-03-03

9.  Sulforaphane induces S-phase arrest and apoptosis via p53-dependent manner in gastric cancer cells.

Authors:  Yuan Wang; Huazhang Wu; Nannan Dong; Xu Su; Mingxiu Duan; Yaqin Wei; Jun Wei; Gaofeng Liu; Qingjie Peng; Yunli Zhao
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

10.  Novel nano-pomegranates based on astragalus polysaccharides for targeting ERα-positive breast cancer and multidrug resistance.

Authors:  Bingjie Wang; Chunjing Guo; Yanhui Liu; Guangting Han; Yi Li; Yanchun Zhang; Haiyu Xu; Daquan Chen
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.